198 related articles for article (PubMed ID: 36464513)
1. Overexpression of Estrogen Receptor α in Mammary Glands of Aging Mice Is Associated with a Proliferative Risk Signature and Generation of Estrogen Receptor α-Positive Mammary Adenocarcinomas.
Furth PA; Wang W; Kang K; Rooney BL; Keegan G; Muralidaran V; Wong J; Shearer C; Zou X; Flaws JA
Am J Pathol; 2023 Jan; 193(1):103-120. PubMed ID: 36464513
[TBL] [Abstract][Full Text] [Related]
2. Esr1 but Not CYP19A1 Overexpression in Mammary Epithelial Cells during Reproductive Senescence Induces Pregnancy-Like Proliferative Mammary Disease Responsive to Anti-Hormonals.
Furth PA; Wang W; Kang K; Rooney BL; Keegan G; Muralidaran V; Zou X; Flaws JA
Am J Pathol; 2023 Jan; 193(1):84-102. PubMed ID: 36464512
[TBL] [Abstract][Full Text] [Related]
3. Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance.
Dabydeen SA; Kang K; Díaz-Cruz ES; Alamri A; Axelrod ML; Bouker KB; Al-Kharboosh R; Clarke R; Hennighausen L; Furth PA
Carcinogenesis; 2015 Jan; 36(1):122-32. PubMed ID: 25421723
[TBL] [Abstract][Full Text] [Related]
4. Introduction of estrogen receptor-alpha into the tTA/TAg conditional mouse model precipitates the development of estrogen-responsive mammary adenocarcinoma.
Tilli MT; Frech MS; Steed ME; Hruska KS; Johnson MD; Flaws JA; Furth PA
Am J Pathol; 2003 Nov; 163(5):1713-9. PubMed ID: 14578170
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of melatonin anticancer effects.
Hill SM; Frasch T; Xiang S; Yuan L; Duplessis T; Mao L
Integr Cancer Ther; 2009 Dec; 8(4):337-46. PubMed ID: 20050373
[TBL] [Abstract][Full Text] [Related]
6. Estrogen metabolites and breast cancer.
Santen RJ; Yue W; Wang JP
Steroids; 2015 Jul; 99(Pt A):61-6. PubMed ID: 25168343
[TBL] [Abstract][Full Text] [Related]
7. Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content.
Nakles RE; Shiffert MT; Díaz-Cruz ES; Cabrera MC; Alotaiby M; Miermont AM; Riegel AT; Furth PA
Mol Endocrinol; 2011 Apr; 25(4):549-63. PubMed ID: 21292825
[TBL] [Abstract][Full Text] [Related]
8. Conditional expression of Ki-Ras
Andò S; Malivindi R; Catalano S; Rizza P; Barone I; Panza S; Rovito D; Emprou C; Bornert JM; Laverny G; Metzger D
Oncogene; 2017 Nov; 36(46):6420-6431. PubMed ID: 28745321
[TBL] [Abstract][Full Text] [Related]
9. Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer.
Treekitkarnmongkol W; Katayama H; Kai K; Sasai K; Jones JC; Wang J; Shen L; Sahin AA; Gagea M; Ueno NT; Creighton CJ; Sen S
Carcinogenesis; 2016 Dec; 37(12):1180-1189. PubMed ID: 27624071
[TBL] [Abstract][Full Text] [Related]
10. Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1α,25-dihydroxyvitamin D
Lundqvist J; Kirkegaard T; Laenkholm AV; Duun-Henriksen AK; Bak M; Feldman D; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2018 Mar; 177():171-178. PubMed ID: 28610873
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor subtypes dictate the proliferative nature of the mammary gland.
Dall GV; Hawthorne S; Seyed-Razavi Y; Vieusseux J; Wu W; Gustafsson JA; Byrne D; Murphy L; Risbridger GP; Britt KL
J Endocrinol; 2018 Jun; 237(3):323-336. PubMed ID: 29636363
[TBL] [Abstract][Full Text] [Related]
12. Aromatase overexpression and breast hyperplasia, an in vivo model--continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands.
Tekmal RR; Kirma N; Gill K; Fowler K
Endocr Relat Cancer; 1999 Jun; 6(2):307-14. PubMed ID: 10731124
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor alpha is required for mammary development and the induction of mammary hyperplasia and epigenetic alterations in the aromatase transgenic mice.
Tekmal RR; Liu YG; Nair HB; Jones J; Perla RP; Lubahn DB; Korach KS; Kirma N
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):9-15. PubMed ID: 15955696
[TBL] [Abstract][Full Text] [Related]
14. Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.
Chen F; Li A; Gao S; Hollern D; Williams M; Liu F; VanSickle EA; Andrechek E; Zhang C; Yang C; Luo R; Xiao H
Cell Death Dis; 2014 May; 5(5):e1242. PubMed ID: 24853420
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1).
Najim O; Huizing M; Papadimitriou K; Trinh XB; Pauwels P; Goethals S; Zwaenepoel K; Peterson K; Weyler J; Altintas S; van Dam P; Tjalma W
Cancer Treat Res Commun; 2019; 19():100123. PubMed ID: 30826563
[TBL] [Abstract][Full Text] [Related]
16. Characterization of mammary adenocarcinomas in male rats after N-methyl-N-nitrosourea exposure--Potential for human male breast cancer model.
Yoshizawa K; Yuki M; Kinoshita Y; Emoto Y; Yuri T; Shikata N; Elmore SA; Tsubura A
Exp Toxicol Pathol; 2016 May; 68(5):263-70. PubMed ID: 26852374
[TBL] [Abstract][Full Text] [Related]
17. Genetically engineered ERα-positive breast cancer mouse models.
Dabydeen SA; Furth PA
Endocr Relat Cancer; 2014 Jun; 21(3):R195-208. PubMed ID: 24481326
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha (Esr1) regulates aromatase (Cyp19a1) expression in the mouse brain.
Yilmaz MB; Zhao H; Brooks DC; Fenkci IV; Imir-Yenicesu G; Attar E; Akbal E; Kaynak BA; Bulun SE
Neuro Endocrinol Lett; 2015; 36(2):178-82. PubMed ID: 26071589
[TBL] [Abstract][Full Text] [Related]
19. The effects of aromatase overexpression on mammary growth and gene expression in the aromatase x transforming growth factor alpha double transgenic mice.
Kirma N; Mandava U; Wuichet K; Tekmal RR
J Steroid Biochem Mol Biol; 2001 Nov; 78(5):419-26. PubMed ID: 11738552
[TBL] [Abstract][Full Text] [Related]
20. PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma.
Cortez V; Samayoa C; Zamora A; Martinez L; Tekmal RR; Vadlamudi RK
Cancer Res; 2014 Dec; 74(24):7395-405. PubMed ID: 25377474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
